What is the first line treatment for Measles (Rubeola)?

The first line treatment for Measles (Rubeola) involves supportive care and the administration of Vitamin A. This approach is grounded in both the clinical presentation of the disease and its management.

Measles is a viral infection that usually presents with fever, cough, runny nose, and a characteristic rash. The primary management strategy focuses on relieving symptoms and supporting the patient's immune system. Since measles is caused by a virus, antiviral medications like Acyclovir are not effective, which is why they're not considered first-line treatments.

Vitamin A supplementation is critically important in the management of measles, particularly in malnourished patients and those with Vitamin A deficiency. Research has demonstrated that Vitamin A can reduce the severity of the illness, decrease the incidence of complications, and is associated with improved outcomes in measles cases.

Supportive care may include hydration, managing fever with appropriate medications, and monitoring for any complications, which are common in measles. Overall, combining supportive care with Vitamin A addresses both the symptomatic treatment needs and helps mitigate the risks associated with the disease, making this combination the preferred first line treatment for Measles.